CP-122721

Thuốc Gốc

Small Molecule

CP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome.

Cơ Chế Tác Dụng : CP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome. CP-122721 interacts with high affinity at the human NK1 receptor expressed in IM-9 cells.

Chỉ Định : Investigated for use/treatment in asthma, depression, and irritable bowel syndrome (IBS).

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05421

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading